Comments

MyMD Pharmaceuticals

MYMDNASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$1.82
0.010.55%
At close: Jul 22, 5:11 PM EDT
$1.83
0.010.55%
After Hours: Jul 22, 5:11 PM EDT
15 minutes delayed

MyMD Pharmaceuticals (MYMD) Forecast

NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

MyMD Pharmaceuticals (NASDAQ:MYMD) Stock Quotes, Forecast and News Summary

MyMD Pharmaceuticals Stock (NASDAQ: MYMD) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.0 / 60.61K
Day Range- - -
52 Wk Range1.75 - 63.90
Market Cap$4.34M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
45
Short Interest
14.7%
Days to Cover10.53

Recent News

Latest Key Hires & Board Changes In Cannabis Industry: Canopy Growth, Acreage And More
s Benzinga Cannabis Capital Conference returns to Chicago this Oct. 8-9 its 19th edition, gathering top CEOs, investors and investors and leaders in the cannabis industry, let's scroll through the latest leadership changes in the space.Kicking off with Margaret Brodie, CEO of Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF), who has recently been nominated as an EY Entrepreneur Of The Year 2024 finalist in Pacific. The company shared the news in an X post earlier in June. Canadian cannabis giant Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) recently appointed Ryan Keith, a senior commercial leader with over two decades of experience in the healthcare and pharmaceutical sectors as head of clinics. Cannabis multi-state operator Acreage Holdings, Inc. (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF) reported last week that it has tapped Rebecca Kirk to serve as its chief operating officer.
Jelena Martinovic

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
About
Sector
Healthcare
Industry
N/A
MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
MYMD

FAQ

Q

How do I buy MyMD Pharmaceuticals (MYMD) stock?

A

You can purchase shares of MyMD Pharmaceuticals (NASDAQ:MYMD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are MyMD Pharmaceuticals (MYMD) competitors?

A

There are no as such competitors for MyMD Pharmaceuticals.

Q

What is the target price for MyMD Pharmaceuticals (MYMD) stock?

A

There is no analysis for MyMD Pharmaceuticals.

Q

What is the forecast for MyMD Pharmaceuticals (MYMD) stock?

A

There is no analysis for MyMD Pharmaceuticals to provide a consensus price target.

Q

Current stock price for MyMD Pharmaceuticals (MYMD)?

A

The stock price for MyMD Pharmaceuticals (NASDAQ: MYMD) is $1.83 last updated July 22, 2024 at 5:11 PM EDT.

Q

Does MyMD Pharmaceuticals (MYMD) pay a dividend?

A

There are no upcoming dividends for MyMD Pharmaceuticals.

Q

When is MyMD Pharmaceuticals (NASDAQ:MYMD) reporting earnings?

A

MyMD Pharmaceuticals’s Q2 earnings are confirmed for Monday, August 12, 2024.

Q

Is MyMD Pharmaceuticals (MYMD) going to split?

A

There is no upcoming split for MyMD Pharmaceuticals.

Q

What sector and industry does MyMD Pharmaceuticals (MYMD) operate in?

A

MyMD Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.